EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2024 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 15th, 2024 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), dated May 11, 2024 and effective as of May 1, 2024 (the “Effective Date”), is by and between Chromocell Therapeutics Corporation (the “Company”) and Francis Knuettel II (the “Executive”). Collectively, the Company and Executive may be referred to herein as the “Parties” or each individually as a “Party.”
CHROMOCELL THERAPEUTICS CORPORATIONConsultant Agreement • May 15th, 2024 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances)
Contract Type FiledMay 15th, 2024 Company IndustryReference is made to that certain Amended and Restated Consultant Agreement, dated as of June 23, 2023, but effective as of May 15, 2023 (the “Consultant Agreement”), by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and Camden Capital LLC (“Consultant”). Capitalized terms used but not defined herein shall have the meanings given to them in the Consultant Agreement.